Jefferies Financial Group Inc. Novavax Inc Call Options Transaction History

Jefferies Financial Group Inc.

  • $13.5 Billion
  • Q3 2024

Call Options

4 transactions
Quarter Operation Price Per call calls change calls Held SEC Form
Q2 2024

Aug 13, 2024
BUY
$3.89 - $20.97 $19,450 - $104,850
5,000 New
5,000 $63,000
Q1 2023

May 15, 2023
BUY
$5.76 - $12.48 $205,632 - $445,536
35,700 Added 42.2%
120,300 $833,000
Q4 2022

Sep 21, 2023
BUY
$8.86 - $25.04 $749,556 - $2.12 Million
84,600 New
84,600 $869,000
Q4 2022

Feb 14, 2023
BUY
$8.86 - $25.04 $749,556 - $2.12 Million
84,600 New
84,600 $869,000

Others Institutions Holding NVAX

# of Institutions
290
Shares Held
93.4M
Call Options Held
6.95M
Put Options Held
9.4M
View Full List

About NOVAVAX INC

NVAX Quotes by TradingView
  • Ticker NVAX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 78,215,104
  • Market Cap $662M
  • Description
  • Novavax, Inc., a biotechnology company, focuses on the discovery, development, and commercialization of vaccines to prevent serious infectious diseases and address health needs. The company's vaccine candidates include NVX-CoV2373, a coronavirus vaccine candidate that is in two Phase III trials, one Phase IIb trial, and one Phase I/II trial; Nan...
More about NVAX
Track This Portfolio

Track Jefferies Financial Group Inc. Portfolio

Follow Jefferies Financial Group Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Jefferies Financial Group Inc., based on Form 13F filings with the SEC.

News

Stay updated on Jefferies Financial Group Inc. with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email